Vaccines Market value to hit $72.5 billion by 2025: Global Market Insights, Inc.
15 août 2019 02h30 HE
|
Global Market Insights, Inc
Selbyville, Delaware, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Global Market Insights, Inc., announces a research report on ‘Vaccines Market Trends and Forecast 2019-2025’. The report covers an extensive...
Vaccines Market worth over $70bn by 2025: Global Market Insights, Inc.
07 mars 2019 06h00 HE
|
Global Market Insights, Inc
Selbyville, Delaware, March 07, 2019 (GLOBE NEWSWIRE) -- The vaccines market is estimated to hike from over USD 38 billion in 2018 to over USD 70 billion by 2025, according to a 2019 Global Market...
PEGylated Drugs Market in Europe and North America worth over $10.5 billion by 2024: Global Market Insights, Inc.
17 avr. 2018 04h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, April 17, 2018 (GLOBE NEWSWIRE) -- North America and Europe PEGylated Drugs Market is expected to surpass USD 10.5 billion by 2024; according to a new research report by...
New Pathogen-Detection Technology Identifies Infectious Diseases
26 mai 2016 13h51 HE
|
ARUP Laboratories
SALT LAKE CITY, May 26, 2016 (GLOBE NEWSWIRE) -- ARUP Laboratories Medical Director Robert Schlaberg, MD, Dr Med, MPH, will be the Principal Investigator for a project to help decrease the high...
OnCore Biopharma Licenses Second-Generation Cyclophilin Inhibitors From NeuroVive for the Treatment of Chronic HBV Infection
09 sept. 2014 03h00 HE
|
OnCore Biopharma, Inc.
OnCore Secures Exclusive Worldwide Rights to NVP018
NVP018 Will Complement OnCore's Existing Pipeline Directed at Achieving All-Oral Cure for HBV
DOYLESTOWN, Pa., Sept. 9, 2014 (GLOBE NEWSWIRE)...
OnCore Biopharma Closes Series R Financing
05 sept. 2014 07h00 HE
|
OnCore Biopharma, Inc.
Funds to Expand OnCore's Portfolio of Oral Therapeutics for the Treatment of Chronic HBV
OnCore to Advance HBV Compounds Into Phase 1 Clinical Development During 2015
Former Pharmasset Team...
Hemispherx Biopharma Gains Broad Treatment Expansion for Alferon N Injection(R) in Argentina
04 mars 2013 08h00 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, March 4, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that ANMAT (Administracion Nacional de Medicamentos, Alimentos y...
International Patent Application Submitted Covering Vaccines for Influenza (Universal Vaccine), Hepatitis C, Cytomegalovirus and Human Papillomavirus
07 juin 2012 07h00 HE
|
Bionor Pharma
OSLO, NORWAY--(Marketwire - Jun 7, 2012) - Bionor Pharma ASA (OSLO: BIONOR)
News Summary
The new patent filed 6 June aims to strengthen the Company's general protection of its...
Immunitor Completes Phase IIb imm01 Trial Enrollment and Plans Further Trials of V5
14 nov. 2010 23h21 HE
|
Immune Network Ltd
VANCOUVER, British Columbia, Nov. 14, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), advises that its potential acquisition, Immunitor USA Inc., has announced the completion of...
Immunitor Phase 2b imm01 Trial Enrollment Scheduled to Complete Next Week
01 nov. 2010 09h42 HE
|
Immune Network Ltd
VANCOUVER, British Columbia, Nov. 1, 2010 (GLOBE NEWSWIRE) -- Immune Network Ltd. (Pink Sheets:IMMFF), a company in the business of discovery and development of immune-based therapies, today announced...